Login to Your Account

AB Science's AD Program Gets $11M in Project Funds

By Cormac Sheridan
Staff Writer

Wednesday, July 24, 2013

AB Science SA received a €5.9 million (US$7.8 million) funding boost for its Phase III development program of masitinib in Alzheimer's disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription